In chronic renal allograft rejection and diabetic kidney disease, MnSOD dysfunction correlates with disease progression and elevated oxidative stress, and several therapeutic interventions targeting these pathways have shown promise [55,56,57]. Here, SOD2 is linked to diabetic kidney disease.